|drug2660||Prolectin-M; a (1-6)-alpha-D-Mannopyranose class Wiki||1.00|
|drug3221||Standard of Care Wiki||0.16|
There is one clinical trial.
Using Laser light to detect COVID 19 virus particles in deep throat swab / nasal swab samples.
Description: level of agreement between novel test and standard testMeasure: kappa value Time: 6 months
Description: test of accuracy for the result versus a validated sample setMeasure: sensitivity and specificity Time: unknown this will require a centrally validated test set for known positives and negatives to be available estimated 1 year
Description: timeliness of resultsMeasure: clinical utility of test Time: 3 months
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports